Biotech could be due for a turnaround thanks to these stocks

Biotech stocks as a group have suffered a tough start to the year, but traders are beginning to see a turnaround for the struggling sector led by big-cap biotech stocks.

When he looks at the Nasdaq Biotech ETF (IBB), Piper Jaffray technical analyst Craig Johnson sees “a series of higher highs and higher lows coming off the recent lows here in that particular index.”

Read more.

Related

JOIN THE DISCUSSION